Endo International

Endo International’s bid to acquire Auxilium Pharmaceuticals last week has been rejected by the latter, according to news agency Reuters. Auxilium is said to have made the statement that the bid “significantly undervalues” the company. Read more


The combination of Somar and Endo advances Endo's position as a leading global specialty healthcare company. It also establishes a platform for growth in key emerging markets in Latin America. Read more